Bispecific radioligands targeting prostate‐specific membrane antigen and gastrin‐releasing peptide receptors on the surface of prostate cancer cells
- 9 May 2019
- journal article
- review article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 62 (8) , 510-522
Abstract
Metastases of prostate cancer usually show highly heterogeneous or partly lost prostate‐specific membrane antigen (PSMA) expression. In order to image and treat both PSMA positive and negative tissues, the extension of PSMA tracer specificity to other receptors, also highly expressed on the surface of prostate cancer cells, has been suggested. Prostate cancer cells usually express both PSMA and gastrin‐releasing peptide (GRP) receptors; thus, bispecific heterodimeric molecules, addressing both targets at the same time, may significantly improve prostate cancer imaging and therapy. This article summarizes preclinical data regarding low‐molecular weight molecules targeting PSMA and GRP receptors.Keywords
This publication has 56 references indexed in Scilit:
- PSMA as a target for radiolabelled small moleculesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Evaluation of 188Re-MAG2-RGD-bombesin for potential prostate cancer therapyNuclear Medicine and Biology, 2013
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancerEJNMMI Research, 2012
- Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell MigrationJournal of Biological Chemistry, 2011
- In VitroandIn VivoResponses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-Conjugated Antibody to Prostate-Specific Membrane AntigenMolecular Cancer Therapeutics, 2011
- Abiraterone and Increased Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2011
- PET/CT Imaging and Radioimmunotherapy of Prostate CancerSeminars in Nuclear Medicine, 2011
- 177Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R ExpressionJournal of Nuclear Medicine, 2009
- Enhanced targeting with heterobivalent ligandsMolecular Cancer Therapeutics, 2009